Forget Intel Stock: You Should Buy This Unstoppable Tech Leader Instead

Rumors that Intel might manufacture some of Apple’s low-end M-series chips (potentially worth up to ~$1 billion annually) briefly lifted Intel shares, but the note argues TSMC remains the superior investment. TSMC controls roughly 90% of the world’s most advanced AI processor manufacturing, reported Q3 sales up 30% to $33.1 billion and EPS of $2.92 per ADR (+39%), and management expects AI data-center revenue to grow at a mid-40% CAGR through 2029. Valuation also favors TSMC (P/E ~30) versus Intel (P/E ~667), supporting a preference for TSMC given structural AI-driven demand and manufacturing leadership.

Analysis

Market structure: TSMC (TSM) and AI hyperscalers (NVDA customers) are the clear winners if current trends hold — TSMC controls ~90% of leading-node capacity and management expects AI data‑center revenue to grow mid‑40% CAGR through 2029, implying sustained tight supply and pricing power for at least 3–5 years. Intel (INTC) could win low‑end Apple (AAPL) M‑series wafer volume worth an estimated ~$1B/year, but that is immaterial vs TSMC’s AI TAM and unlikely to dent TSMC’s pricing on advanced nodes. Expect margin expansion for TSMC and continued capex intensity (12–24 month build lead times) driving equipment names (ASML, LRCX).

Risk assessment: Tail risks include a confirmed Intel foundry win with Apple (near‑term catalyst), TSMC yield or capacity miss, US/China export controls, or a Taiwan geopolitical shock — each could move shares ±20–40% depending on severity. Time horizons split cleanly: immediate (days) — rumor-driven volatility; short (weeks/months) — supplier confirmations, Apple/Intel announcements; long (quarters/years) — capacity ramps and node transitions. Hidden dependencies: customer concentration (NVIDIA, Apple), ASML EUV tool delivery timing, and energy/water constraints in Taiwan. Key catalysts to watch in next 30–90 days: Apple vendor updates, Intel foundry roadmap disclosures, TSMC quarterly guide.

Trade implications: Primary actionable bias is long TSM vs hedge/underweight INTC. Consider establishing 2–3% portfolio long TSM via 12–24 month call LEAPS (delta ~0.35–0.45) or selling 6–9 month 10% OTM puts to collect premium and set entry ~10% below market. Hedge by buying a 6–9 month INTC put spread sized at ~50% of the TSM notional (limits downside and capital). Overweight semiconductor capex suppliers (ASML, LRCX) by 1–2% as a secondary play.

Contrarian angles: Consensus underweights the speed at which Intel can qualify fabs — manufacturing wins are operationally hard and take 12–24 months; the market may be overpricing a small Apple win into INTC (current P/E skew is inconsistent with fundamentals). Conversely, TSM’s ~P/E 30 already prices secular AI growth but may understate geopolitical tail risk; set explicit triggers: if Intel lands >$1B contract confirmed and INTC shares gap up >30% intraday, trim positions; if TSMC guidance falls below mid‑30% AI growth, reduce exposure by 25%.

Key Decisions for Investors

• Initiate a 2–3% net long position in TSM via 12–24 month call LEAPS (target delta ~0.35–0.45) within 2–4 weeks, or alternatively sell 6–9 month 10% OTM puts to target an entry price ~10% below current level; size to risk no more than 3% portfolio volatility.
• Establish a protective hedge against INTC exposure: buy a 6–9 month put spread on INTC (e.g., 25–35% OTM buy/sell) sized to 50% of the dollar notional of the TSM long to cap downside if Intel findsry rumors escalate.
• Overweight semiconductor equipment suppliers (ASML, LRCX) by +1–2% portfolio weight as a correlated play on sustained capex; take profits if ASML/ LRCX rally >20% from entry or if TSM guidance slips below 30% AI CAGR.
• Trigger-based risk management: within 30–90 days, if Apple/Intel jointly confirm Intel will handle >5% of Apple M‑series wafer volume (implied >$1B/year), reduce INTC hedges and trim TSM exposure by 15–25; conversely, if TSMC Q‑guide reiterates mid‑40% AI CAGR, add to TSM position up to +1%.